Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:1,3-Dimethyluric acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001639 AN002683 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST002273 AN003715 Multi-Omics analysis revealed a significant alteration of critical metabolic pathways due to sorafenib-resistance in Hep3B cell lines Cultured cells Human Cancer Sharjah Institute for Medical Research AU
ST002301 AN003757 Serum metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients Blood Human COVID-19 Sharjah Institute for Medical Research AU
ST002391 AN003896 Evaluation of Two Simultaneous Metabolomic and Proteomic Extraction Protocols Assessed by Ultra-High-Performance Liq-uid Chromatography Tandem Mass Spectrometry Blood Human Sharjah Institute for Medical Research AU
ST002447 AN003988 Bioactive molecule(s) of gut bacteria of Crocodile (Crocodylus palustris) as potential pharmaceuticals Pseudomonas aeruginosa Bacterial infection Sharjah Institute for Medical Research AU
ST002553 AN004204 Exploring the Impact of Oral Arabic Gum Consumption on Sphingolipid Metabolism and human metabolites in Chronic Kidney Disease: A Mass Spectrometry Analysis Blood Human Chronic kidney disease Sharjah Institute for Medical Research AU
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham Women's Hospital intensity
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST000150 AN000237 Association of Metabolic Profile and Microbiome in Chronic Pressure Ulcer Wounds Ulcer biopsies Human Enterocolitis Montana State University mM/gm tissue
ST001324 AN002203 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences mV*s
ST002535 AN004170 Relationships between the gut microbiome and cognitive impairment in residents of long-term aged care. Feces Human Cognitive impairment South Australian Health and Medical Research Institute ng/ml
ST002711 AN004394 Metabolomic analysis of maternal mid-gestation plasma and cord blood: biogenic amines Blood Human Autism Columbia University normalized peak heights
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center osmolality normalized scaled imputed
ST002498 AN004656 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine peak area
ST002915 AN004785 MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Untargeted Reversed-Phase Negative Kidney Rat University of Michigan peak area
ST001047 AN001711 1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer (part II) Urine Human Cancer University of Alberta Peak area
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan Peak area
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan Peak area
ST002909 AN004777 Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis Blood Human Melioidosis University of Washington Peak Area
ST001325 AN002207 Obesity and Poor Diet as Susceptibility Factors for Secondhand Smoke in Childhood Asthma Blood Human Asthma University of Michigan Peak area normalized
ST000421 AN000663 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST001827 AN002963 The pregnancy metabolome from a multi-ethnic pregnancy cohort Blood Human Icahn School of Medicine at Mount Sinai pmoles/l
ST000899 AN001464 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center raw area counts
ST001749 AN002850 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin - Madison Raw area counts
ST002818 AN004588 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002819 AN004592 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004596 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST002088 AN003408 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003412 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center scaled imputed
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
  logo